The early-stage pipeline for amyotrophic lateral sclerosis drugs exploded last year. After ALS R&D notched 28 new trial starts in 2023, the rate more than doubled to 60 in 2024, Citeline recently ...
Clinical Trials Arena on MSN
Spinogenix’s ALS hopeful to advance to registrational trial
"Spinogenix’s ALS hopeful to advance to registrational trial" was originally created and published by Clinical Trials Arena, ...
SPG302 was well tolerated in a trial, with preliminary data supporting the idea the therapy might slow ALS progression.
ALS is a progressive disease, meaning it worsens over time. Although there is no cure for ALS, medications and therapies are available to help manage the symptoms, slow the disease course, and prolong ...
Passage of the ALS Association-led bill marks a milestone in the fight to alleviate crushing costs incurred by ALS patients and their families AUSTIN, Texas, June 25, 2025 /PRNewswire/ -- The ALS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback